Search results
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 4 days agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 13 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 14 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 15 hours agoThis means Moderna stock outranks nearly three-quarters of all stocks on that metric. But MRNA stock...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 7 days agoModerna's solid trial data makes me optimistic the FDA will offer mRNA-1345 a nod, so the company soon may have two products on the market -- and be...
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 14 hours agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 22 hours agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Markets News, May 2, 2024: Nasdaq Leads Stocks Higher; Apple Gains Ahead of Earnings
Investopedia· 12 hours agoU.S. stocks rose on Thursday as markets digested yesterday's comments from Fed Chair Jerome Powell...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 18 hours agoOver the past six months, shares of MRNA have risen 46.27%. (See the last biotech stock roundup...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 13 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
